RECOGNITION

In recognition of our work, we continue to be awarded, ranked and positively endorsed by independent research organisations.

Below are a few examples of the recognition that our commitment to client service and to the industry overall has delivered in recent times:

“Wrays Lawyers assists with patent litigation and advisory matters, with regular involvement in the pharmaceutical and life sciences sectors. Natalie Shoolman advises both domestic and international clients on patents, trade marks, copyright and trade secrets. Judith Miller advises on a range of commercial and IP transactions, while Marie Wong acts on contentious and non-contentious IP matters, along with Gary Cox and Bindhu Holavanahalli.”

• “Natalie Shoolman is an exceptional senior lawyer. She is strategic, thoughtful, practical and passionate about providing legal services; her background in science and law means she has been able to combine her interests and strengths. I would unhesitatingly recommend Natalie to any client for IP-related contentious and non-contentious matters.”

• “Exceptional depth of knowledge; very timely advice.”

The Legal 500 (2026)

“Solidifying its position as a leading practice in the patent space, Wrays consistently delivers winning results across the spectrum of contentious and non-contentious matters. Leveraging its unique in-house tools and dedicated IP strategy and management team, the outfit provides financial backing, mentoring and training to clients and stakeholders. The ensemble of 44 patent attorneys is one of the largest teams of dedicated IP professionals, each practitioner bringing a blend of legal and commercial acumen. Chairman and principal Gary Cox has been a renowned personality for decades, known for his proficiency in both IP litigation and patent prosecution. Cox’s extensive technical background in biochemistry and microbiology equips him to represent industry heavyweights in the courtroom as both a lawyer and a topical expert; recent examples include the successful defence on multiple opposition case for Amgen brought on by Sanofi, and his subsequent representation for the appeal proceedings in the Federal Court. Another ambidextrous expert in the team is principal and head of life sciences Todd Shand. Working alongside Cox on the complex Amgen dispute, principal Natalie Shoolman leads the litigation and dispute resolution team, with 20-plus years of experience working in top-tier firms. Seasoned maverick Andrew Goatcher is go-to counsel for those looking to maximise their IP assets with ironclad defence against allegations of misleading and deceptive conduct under Australian Consumer Law. Principals Linda Kennaugh and Penelope Farbey are the pillars of the prosecution practice, dedicated to advancing their patrons’ commercial and scientific goals through their deep understanding of the life sciences sector. Having recently joined Wrays, principal and vice president of the the IPTA Grant Shoebridge is a notable influence on Australia’s patent legislation and a renowned opinion leader on gene-related patent matters.”

IAM Patent 1000 (2025)

“With a strong national network, the intellectual property team at Wrays Lawyers is jointly led by Perth-based Gary Cox, and Sydney-based Judith Miller. The team regularly represents pharmaceutical and biotechnological clients before the Federal Court and handles the full range of contentious patent matters. Natalie Shoolman and Marie Wong are adept at handling deceptive conduct and design infringement disputes.”

• “Amazing technical knowledge.”

• “I’d like to specifically recognise Marie Wong for the work she has done in supporting our business, a start-up fashion business. Marie has assisted with trade mark protection in Australia and Europe, including in the face of trade mark oppositions, and has performed legal work for our terms and conditions and privacy policies.”

The Legal 500 (2025)

“Always demonstrating a great understanding of client needs and expectations, Wrays prides itself on superb service and independence. Needless to say, its potent patent group has all disciplines on lock. An illustrious list of industry leaders, among them BlueScope Steel, Eli Lilly, Takeda, Lion, Xero and Jurlique, have entrusted the set with their vast IP portfolios. Running the show is chairman Gary Cox. Starting his IP career as an examiner of patents with IP Australia in 1990, he traverses the contentious/non-contentious divide with ease and benefits from his scientific background in biochemistry. On the disputes front, he is ably supported by Natalie Shoolman. Previously at Clayton Utz, she excels at dispensing highly strategic and business-critical advice to the world’s leading pharmaceutical and biotechnology companies, helping to steer them through multi-jurisdictional patent litigation. A chemist by trade, Todd Shand focuses his prosecution offering on both small molecule pharmaceuticals and hydrometallurgy. Also active in the life sciences field, Grant Shoebridge is a highly sought-after patent attorney with specialist expertise in immunology; whereas biochemistry PhD holder Linda Kennaugh dazzles with her knowledge of antibody technologies.”

IAM Patent 1000 (2024)

“Well-established in the pharmaceutical industry, Wrays Lawyers is active in work at the intersection of intellectual property and competition law. Gary Cox in Perth is experienced in intellectual property litigation. Based in Sydney, Judith Miller is focused on the research and development sector and advises clients on the exploitation, management and protection of their rights in old and new media.”

• “They are experts in the field.”

• “Knowledgeable and thorough.”

• “They have long and strong client relationships and know their matters back to front.”

The Legal 500 (2024)

“Wrays shares our growth mindset. The firm helps us with areas where we can improve, and listens to us when we suggest areas where they can improve. One example is the client portal Wrays is onboarding to provide us with instant access to up-to-date information about our trademark portfolio. This is very helpful for internal reporting purposes.”

“We appreciate the friendly professionalism and expertise in thinking on patentability as well as future commercialisation requirements.”

IP Stars (2023)

“A respected presence on the market for over a century, Wrays remains one of the largest privately owned IP specialists in the country. One of the key differentiators of the group is its integrated patent and dispute resolution service, which allows its discerning clients to enjoy a top-notch, one-stop IP experience. The acclaimed practice is led by chairman Gary Cox, who draws judiciously on his previous experience as a patent examiner and comfortably traverses the contentious/non-contentious IP divide. Further technical dexterity is supplied in abundance by Todd Shand, Peter Caporn and Linda Kennaugh. A chemist by trade, Shand focuses his prosecution offering on both small molecule pharmaceuticals and hydrometallurgy. Also operating in the chemistry space, Caporn focuses on mineral processing and chemical engineering technologies, serving happy patrons both domestically and abroad. Meanwhile, biochemistry PhD holder Kennaugh dazzles onlookers with her knowledge of antibody technologies. Joining Wrays in 2022 from Pearce IP, Grant Shoebridge is a highly sought-after patent attorney with specialist expertise in immunology. Joining the team in August 2022 is former Clayton Utz practitioner Natalie Shoolman, who thrives when taking the lead on key patent cases.”

IAM Patent 1000 (2023)

“Perth-headquartered Wrays prides itself on being one of the largest and oldest IP specialists in Australia. Its nimbleness, flexibility and competitive pricing enable the team to better suit businesses’ individual needs, to which one patron testifies as follows: “Wrays understands our brand, distribution strategy, roadmap and budget; and subsequently tailored our trademark strategy accordingly.” Leading the line is national practice head and principal Marie Wong, whose versatility allows her to work on both contentious and non-contentious matters with aplomb.”

World Trade Mark Review 1000 (2023)

“Wrays enjoyed yet another wonderful year in 2021: it has remained firmly in the ascendant and witnessed one of the biggest upticks of instructions coming through, despite the trials of the pandemic. Recently celebrating its centennial anniversary, it has had a stellar track record of attracting and retaining the best and the brightest patent attorneys from the profession. Within the past 18 months it has recruited three senior principals from its competitors. Wrays particularly prides itself on its complete independence, client-oriented service, technical supremacy and commercial savviness, as attested by one of its patrons: “They always have detailed knowledge of the matters in which they are involved and a firm grasp of both the technology and the legal and strategic aspects of those matters on behalf of their clients.”

IAM Patent 1000 (2022)

“Being one of the largest and oldest IP specialist firms in Australia, Wrays operates across four cities in the country and combines its patent attorney and trademark attorney practices to offer a holistic commercial and litigation IP offering. Its’ truly flexible and cost-mindful approach to intellectual property enables the team to better suit business’ individual needs without breaking the bank, which has been nicely summarised by one patron as “very adaptable, customisable and reasonably priced”. “Wrays’ knowledge of intellectual property, and personal delivery of service, is what makes it unique from my perspective.” “Wrays provides an excellent service, keeping us up to date with the registration process and responding to queries in a timely manner.”

World Trade Mark Review 1000 (2022)